Expand Document | Expand Chapter | Full TOC | Printable HTML version
Use of the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce - EDM Research Series No. 016
(1995; 156 pages) View the PDF document
Table of Contents
View the documentACKNOWLEDGMENTS
View the documentPREFACE
View the documentEXECUTIVE SUMMARY
Open this folder and view contents1. INTRODUCTION
View the document2. RATIONALE AND OBJECTIVE OF THE ASSESSMENT
View the document3. ACTIVITIES UNDERTAKEN: Preparations and Method of Work
Open this folder and view contents4. ANALYSIS OF RESULTS FROM IMPORTING COUNTRIES
Open this folder and view contents5. ANALYSIS OF RESULTS FROM EXPORTING COUNTRIES
View the document6. ANALYSIS OF RESULTS FROM INTERNATIONAL SUPPLY AGENCIES
Open this folder and view contents7. SUMMARY ANALYSIS
View the document8. CONCLUSIONS
View the documentANNEX 1: Resolution adopted by the Twenty-second World Health Assembly
View the documentANNEX 2 (a): Resolution Adopted by the Twenty-Eighth World Health Assembly
View the documentANNEX 2 (b): Certificate of Pharmaceutical Product(S)1
View the documentANNEX 3 (a): Resolution adopted by the Forty-first World Health Assembly
View the documentANNEX 3 (b): Certificate of Pharmaceutical Product(s)1 (Proposed Layout)
View the documentANNEX 4 (a): Proposed Guidelines on the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce
View the documentANNEX 4 (b): Certificate of a Pharmaceutical Product
View the documentANNEX 4 (c): Statement of Licensing Status of Pharmaceutical Product(s) Model Statement of Licensing Status of Pharmaceutical Product(s)
View the documentANNEX 4 (d): Manufacturer’s/Official Batch Certificate of a Pharmaceutical Product
View the documentANNEX 5: Protocol for the Assessment of the Use of the WHO Certification Scheme by Importing Country
View the documentANNEX 6: List of Participants in the Study
View the documentANNEX 7: Protocol for the Assessment of the Use of the WHO Certification Scheme by Exporting Country
View the documentANNEX 8: Protocol for the Assessment of the Use of the WHO Certification Scheme in an International Supply Organization
View the documentANNEX 9: Study Instrument for Assessment of the WHO Certification Scheme by Importing Country
Open this folder and view contentsANNEX 10: Summaries of Mission Reports on the Assessment of the Use of the WHO Certification Scheme
View the documentBACK COVER
 

ANNEX 4 (d): Manufacturer’s/Official Batch Certificate of a Pharmaceutical Product

Manufacturer’s/Official1 Batch Certificate of a Pharmaceutical Product

No. of Certificate........
Importing (requesting) country:

Proprietary name (if applicable) and dosage form:
Active ingredient(s)2 and amount(s) per unit dose:

Details of product licence and product certificate issued in the exporting country

Product-licence holder:

Product-licence number:

Date of issue:

Product licence issued by:

 

Product-certificate number: 3

Batch number:

Date of manufacture:

Shelf-life (years):

Contents of container:

Nature of secondary container:

Nature of primary container/wrapping:

Specific storage conditions recommended for the product:

Temperature range:

 

Quality analysis

What specifications apply to this dosage form?

Either specify the pharmacopoeia or append the specifications.

Does the batch comply in all particulars with the above specifications?

yes no

Append certificate of analysis.4


It is hereby certified that the above declarations are correct and that results of the analyses and assays on which they are based will be provided on request to the competent authorities in both the importing and the exporting countries.

Name and address of authorized person:

Signature of authorized person:

 

Stamp:

Telephone/fax numbers:

Date:

This certificate conforms to the format recommended by the World Health Organization (General instructions and explanatory notes overleaf)

General instructions

Please refer to the guidelines for further information on how to complete this form and on the implementation of the Scheme.

Forms should be completed using a typewriter to ensure legibility.

A cross should be placed in boxes as appropriate to indicate which options apply.

Additional sheets should be appended, as necessary, to accommodate remarks and explanations.

Explanatory notes

Certification of individual batches of a pharmaceutical product is only undertaken exceptionally by the competent authority of the exporting country. Even then, it is rarely applied other than to vaccines and biologicals. For other products, the responsibility for any request to provide batch certificates rests with the product-licence holder in the exporting country. The responsibility to forward certificates to the competent authority in the importing country is most conveniently assigned to the importing agent.

Any inquiries or complaints regarding a batch certificate should always be addressed to the competent authority in the exporting country. A copy should be sent to the product-licence holder.

1 Strike out whichever does not apply.

2 Use, whenever possible, International Nonproprietary Names (INNs) or national nonproprietary names.

3 This refers to the Certificate of a Pharmaceutical Product as recommended by the World Health Organization.

4 Identify and explain any discrepancies from specifications.

 

to previous section to next section
 

Last updated: May 3, 2013